NCT01804569

Brief Summary

There will be significant differences between control and experimental group after the moxibustion intervention as to, subjective physical symptoms and quality of life.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2013

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 2, 2013

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 5, 2013

Completed
27 days until next milestone

Study Start

First participant enrolled

April 1, 2013

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2013

Completed
Last Updated

September 10, 2013

Status Verified

September 1, 2013

Enrollment Period

1 month

First QC Date

March 2, 2013

Last Update Submit

September 8, 2013

Conditions

Outcome Measures

Primary Outcomes (1)

  • subjective physiological symptoms

    2 weeks after the intervention

Secondary Outcomes (1)

  • Quality of Life

    2 weeks after the intervention

Study Arms (1)

moxa

EXPERIMENTAL

moxibustion treatment 3 times a week for 3 weeks

Other: moxibustion

Interventions

modernly developed moxibustion treatment device with safe cover on top of it.

Also known as: Shinkigoo (신기구), company: bosungsa
moxa

Eligibility Criteria

Age65 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Male and female older adults age between 65-85
  • Agree to participate and sign for the trail after understanding of study purpose, and method.
  • Able to answer for questions by verbally or literally
  • Able to participate in 2weeks after follow-up

You may not qualify if:

  • Having physical disorder such as thyroids, severe heart disease, dietetic mellitus, severe liver disease, allergy
  • Subjects who can not attend more than 3 times of intervention session
  • Subjects who are eligible by the decision of investigator

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Moxibustion

Intervention Hierarchy (Ancestors)

Acupuncture TherapyComplementary TherapiesTherapeutics

Study Officials

  • Jooshin Kim, MSW

    Pusan National University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD candidate

Study Record Dates

First Submitted

March 2, 2013

First Posted

March 5, 2013

Study Start

April 1, 2013

Primary Completion

May 1, 2013

Study Completion

May 1, 2013

Last Updated

September 10, 2013

Record last verified: 2013-09